Valuation: ResMed, Inc.

Market Cap 28.65B 25.11B 23.21B 21.35B 40.28B 2,762B 40.92B 278B 109B 1,352B 108B 105B 4,657B P/E 2026 *
18.8x
P/E 2027 * 17.9x
Enterprise Value 27.82B 24.38B 22.54B 20.73B 39.11B 2,683B 39.74B 270B 106B 1,313B 104B 102B 4,522B EV / Sales 2026 *
4.92x
EV / Sales 2027 * 4.56x
Free-Float
75.61%
Yield 2026 *
1.23%
Yield 2027 * 1.32%
1 day-0.19%
1 week+0.06%
Current month+1.91%
1 month+5.29%
3 months-12.17%
6 months-21.56%
Current year-17.54%
1 week 194.06
Extreme 194.06
203.88
1 month 187.24
Extreme 187.245
222.43
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
7/7/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
8/6/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
1/6/26 Tax

General Counsel

-269 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.19%+0.06%-23.00%-9.43% 28.7B
-1.17%-0.43%+26.88%-2.24% 198B
-1.33%+0.47%+5.82%-17.71% 144B
+2.24%-13.25%-31.90%+1.58% 122B
-0.59%-1.97%-57.77%-18.13% 65.44B
-0.85%-7.40%+11.13%-8.26% 49.36B
+0.65%-0.59%-23.34%-31.15% 44.74B
-0.91%-2.82%+14.27%+4.58% 37.13B
-3.10%-4.20%+24.35%+27.80% 36.23B
-0.38%-3.80%-17.29%-23.24% 28.69B
Average -0.92%-3.27%-7.08%-7.62% 75.48B
Weighted average by Cap. -1.06%-2.95%-2.34%-7.35%

Financials

2026 *2027 *
Net sales 5.65B 4.95B 4.58B 4.21B 7.94B 545B 8.07B 54.74B 21.46B 267B 21.22B 20.75B 918B 5.96B 5.22B 4.83B 4.44B 8.37B 574B 8.51B 57.7B 22.62B 281B 22.37B 21.88B 968B
Net income 1.55B 1.36B 1.25B 1.15B 2.17B 149B 2.21B 14.98B 5.87B 72.98B 5.81B 5.68B 251B 1.62B 1.42B 1.31B 1.21B 2.28B 156B 2.31B 15.69B 6.15B 76.42B 6.08B 5.95B 263B
Net Debt -828M -726M -671M -617M -1.16B -79.84B -1.18B -8.02B -3.14B -39.06B -3.11B -3.04B -135B -1.46B -1.28B -1.18B -1.09B -2.05B -140B -2.08B -14.11B -5.53B -68.74B -5.47B -5.35B -237B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
20/07/26 USD 198.61 -0.19% 1,037,314
17/07/26 USD 198.99 -1.86% 1,284,198
16/07/26 USD 202.76 +2.11% 1,019,540
15/07/26 USD 198.57 +2.88% 1,208,785
14/07/26 USD 193.01 -2.77% 1,622,359
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
198.61USD
Average target price
248.73USD
Spread / Average Target
+25.24%

Quarterly revenue - Rate of surprise